Indication
Mental Disorders
10 clinical trials
11 products
1 drug
Clinical trial
A Randomized, Single-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderStatus: Completed, Estimated PCD: 2022-09-23
Product
LY03010Clinical trial
Phase 1b Open-Label, Dose-Identification Study of XPro1595 in Patients With Alzheimer's Disease and Biomarkers of Inflammation.Status: Completed, Estimated PCD: 2021-06-30
Product
XPro1595Product
PlaceboClinical trial
Global Study to Investigate Safety and Efficacy of Donanemab in Early Symptomatic Alzheimer's DiseaseStatus: Recruiting, Estimated PCD: 2027-04-16
Product
DonanemabClinical trial
A Study to Evaluate the PK Profiles of LY03010 and Relative Bioavailability at Steady-state of LY03010 Versus INVEGA SUSTENNA in Schizophrenia PatientsStatus: Completed, Estimated PCD: 2022-03-15
Product
Paliperidone palmitateProduct
Invega SustennaClinical trial
An Open Label Extension of XPro1595 in Patients With Alzheimer's Disease That Have Completed a Phase 1 or Phase 2 Study With XPro1595Status: Recruiting, Estimated PCD: 2026-05-04
Clinical trial
A Phase 2, Randomized, Placebo-Controlled, Double-Blind Study of XPro1595 in Patients With Mild Cognitive Impairment (MCI) With Biomarkers of InflammationStatus: Withdrawn, Estimated PCD: 2023-10-26
Product
GanaxoloneClinical trial
A Phase 2A, Double-blind, Placebo-controlled, Multiple-dose Escalation Study to Evaluate Safety, Pharmacokinetics and Efficacy of Intravenously Administered Ganaxolone in Women With Postpartum DepressionStatus: Completed, Estimated PCD: 2019-05-10
Clinical trial
Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia: a Randomized Clinical TrialStatus: Recruiting, Estimated PCD: 2026-02-28
Product
MelatoninProduct
QuetiapineClinical trial
Investigating the Effect of Different Donanemab Dosing Regimens on ARIA-E and Amyloid Lowering in Adults With Early Symptomatic Alzheimer's DiseaseStatus: Recruiting, Estimated PCD: 2024-06-01
Drug
VarlilumabClinical trial
Clinical Utility of Pharmacogenomics of Psychotropic MedicationsStatus: Withdrawn, Estimated PCD: 2021-07-09
Product
Treatment as usual